Daré Bioscience’s Intravaginal Ring Improves Vasomotor, Vaginal Symptoms Of Menopause – Dare Bioscience (NASDAQ:DARE)
[ad_1] Daré Bioscience Inc DARE announced topline efficacy results from its Phase 1/2 trial of DARE-HRT1. DARE-HRT1 is a novel, investigational intravaginal ring (IVR) designed to deliver bio-identical 17β-estradiol and bio-identical…